CORMEDIX INC. - COMMON STOCK
8.9000
04-October-24 15:59:59
15 minutes delayed
Stocks
+0.6100
+7.36%
Today's range
8.2800 - 9.0300
ISIN
N/A
Source
NASDAQ
-
07 Apr 2022 08:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. to Present at the 21st Annual Needham Virtual Healthcare Conference
04 Apr 2022 08:30:00 By Nasdaq GlobeNewswire
-
29 Mar 2022 16:01:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Announces FDA Acceptance of Resubmission of New Drug Application for DefenCath
28 Mar 2022 08:30:00 By Nasdaq GlobeNewswire
-
22 Mar 2022 08:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Announces the Appointment of Chief Executive Officer
17 Mar 2022 08:30:00 By Nasdaq GlobeNewswire
-
Cormedix Inc. Announces Resubmission of New Drug Application for DefenCath
28 Feb 2022 08:30:00 By Nasdaq GlobeNewswire
-
CorMedix to Participate in Upcoming January Conferences
04 Jan 2022 08:00:02 By Nasdaq GlobeNewswire
-
CorMedix Inc. Reports Third Quarter 2021 Financial Results and Provides Business Update
09 Nov 2021 16:05:02 By Nasdaq GlobeNewswire
-
02 Nov 2021 08:30:01 By Nasdaq GlobeNewswire
-
20 Oct 2021 08:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Executive Leadership Changes
04 Oct 2021 16:01:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Regulatory Update
07 Sep 2021 08:30:00 By Nasdaq GlobeNewswire
-
12 Aug 2021 16:01:00 By Nasdaq GlobeNewswire
-
28 Jul 2021 08:30:00 By Nasdaq GlobeNewswire
-
10 Jun 2021 08:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. to Participate in Fireside Chat at the JMP Securities Life Sciences Conference
09 Jun 2021 08:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. to Present at the Jefferies Virtual Healthcare Conference
27 May 2021 08:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Reports First Quarter 2021 Financial Results and Provides Business Update
13 May 2021 16:01:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Appointment of Chief Commercial Officer
13 May 2021 08:30:00 By Nasdaq GlobeNewswire